Jun 21,2022

Appalachian Regional Healthcare Selects Biofourmis Tech for Home Hospital Programs, Including Rural Healthcare Study

Biofourmis, a global leader in virtual care and digital medicine, today announced that Appalachian Regional Healthcare (ARH), based in Lexington, Ky., will be using Biofourmis’ technology to support a new program delivering acute hospital-level care inside patients’ homes, including a clinical trial studying this care model in rural areas.

COLLABORATION PARTNERSHIP

#institution

#rpm

#virtual care

View Analyst & Ambassador Comments
Go to original news
Aug 31,2022

Kaiku Health expands partnership with a leading global medicines company to provide improved cancer care to more patients across multiple indications

Last year Kaiku Health, a leading digital therapeutics platform for cancer care, announced its collaboration with Novartis, a leading global medicines company, in developing digital patient monitoring and management for melanoma patients. Following the success of the collaboration, Kaiku Health and Novartis are now expanding it into a partnership.

COLLABORATION PARTNERSHIP

#product & service

#rpm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Sep 05,2022

Results presented at ESMO 2022: Kaiku Health digital patient monitoring platform can help in resolving acute fever in melanoma patients

A multicenter study led by the Netherlands Cancer Institute used Kaiku Health digital patient management platform to investigate the use of digital patient monitoring and support of patients with advanced melanoma. The results published at ESMO 2022 annual conference suggest that Kaiku Health can be used to support patients and to collect real-world evidence. They can also help to understand the development of symptoms and quality of life of the patients.

CLINICAL STUDY

#rwe

#rpm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jul 20,2021

DarioHealth Chosen to Provide Remote Patient Monitoring for Alabama Regional Medical Services

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it has been selected as a digital health provider by Alabama Regional Medical Services (ARMS), a Federally Qualified Health Center (FQHC) accredited by The Joint Commission and designated as a Primary Care Medical Home serving patients in Jefferson, Shelby, St. Clair, and Blount counties.

PRODUCT

#rpm

View Analyst & Ambassador Comments
Go to original news
Jul 28,2021

Withings and One Drop Partner to Bring Best-In-Class Medical Devices to Multi-Condition Employer Program

Withings, early pioneers of the connected health revolution, and One Drop, a leader in precision health solutions for people living with diabetes and other chronic conditions, are partnering to connect One Drop’s predictive health platform with Withings’ best-in-class smart medical devices for blood pressure and weight management. Together, the companies will bring connected health solutions to employers, empowering workforces worldwide to make more informed decisions and live healthier lives.

COLLABORATION PARTNERSHIP

#connected device

#rpm

View Analyst & Ambassador Comments
Go to original news
Jul 30,2021

Biofourmis Earns FDA Breakthrough Device Designation for Digital Therapeutic for Heart Failure

Biofourmis, a Boston-based global leader in virtual care and digital therapeutics, announced its BiovitalsHF® solution is the first-ever heart failure digital therapeutic to receive a Breakthrough Device designation from the U.S. Food and Drug Administration (FDA).

REGULATORY FDA

#mobile app

#rpm

#software

View Analyst & Ambassador Comments
Go to original news
Aug 12,2021

Labcorp Extends Leadership in Women’s Health With Acquisition of Ovia Health

Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has acquired Ovia Health, a digital health platform used by millions of women seeking information and support with family planning, pregnancy and parenting. The transaction extends Labcorp’s position as a leading, go-to source for women’s health insights, opens new avenues for personalized care experiences and fosters better dialogue between health care providers and their patients.

COLLABORATION MERGERS & ACQUISITION

#product & service

#rpm

#telehealth

View Analyst & Ambassador Comments
Go to original news
Aug 13,2021

my mhealth has announced the first international rollout of its NHS-approved COPD app myCOPD in New Zealand

UK-based digital therapeutics company, my mhealth has announced the first international rollout of its NHS-approved COPD app, myCOPD in New Zealand. The rollout is initially focused on the Māori and Pasifika population, making it the first NHS approved digital self-management programme for COPD to be available in a clinical setting beyond British borders.

PRODUCT

#mobile app

#rpm

View Analyst & Ambassador Comments
Go to original news
Aug 26,2021

Mind Cure Health begins North American release of digital therapeutic for psychedelic therapy

Mind Cure Health, a Canadian startup developing technology platforms to assist mental healthcare and psychedelic research, is releasing a minimum viable product (MVP) version of its flagship digital therapeutic, iSTRYM, in clinics across North America. While the version of iSTRYM initially being released only includes basic features, the digital platform provides data-driven insights to support both patients and providers throughout psychedelic therapy.

PRODUCT

#software

#rpm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Mar 18,2021

Broward Health and Voluntis Launch a New Clinical Evaluation Program on Digital Therapeutics for Metastatic Breast Cancer

Voluntis, a leader in digital therapeutics, announced today a collaboration with Broward Health, a public health system in the U.S. The partnership will focus on conducting a real-world evaluation of Oleena®, a digital application that assists patients in managing their symptoms. As part of the collaboration, Oleena®, a FDA-authorized digital therapeutic application developed by Voluntis for patients with cancer, will be provided to patients with HR+/HER2- metastatic breast cancer to support them in self-managing symptoms and side effects of their conditions and treatments. The clinical research will start enrolling patients in 2021, following an initial deployment of Oleena at Broward Health North.

COLLABORATION PARTNERSHIP

#institution

#rpm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Subscribe to RPM